Theravance Biopharma (TBPH) Tops Q3 EPS by 19c
Get Alerts TBPH Hot Sheet
Join SI Premium – FREE
Theravance Biopharma (NASDAQ: TBPH) reported Q3 EPS of ($0.73), $0.19 better than the analyst estimate of ($0.92). Revenue for the quarter came in at $19.1 million versus the consensus estimate of $12.62 million.
For earnings history and earnings-related data on Theravance Biopharma (TBPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- First Merchants Corp (FRME) Tops Q1 EPS by 3c
- CEMEX, S.A.B. de C.V. (CX) Tops Q1 EPS by 5c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!